Evidence Hub

Efficacy and safety of tadalafil when used in monoand initial combination therapy regimens in patients with pulmonary arterial hypertension

Tamila Vitalievna Martynyuk, Andrey V. Zorin, E. A. Nikolaeva, N. A. Androsov, Oleg V. Rodnenkov, Y. Matchin

Systemic Hypertension, 2026

36 participants

Abstract

Objective

. To evaluate the efficacy and safety of tadalafil in 24-week mono- and initial combination therapy in newly diagnosed patients with pulmonary arterial hypertension (PAH).

Material and Methods

. A single-center, open-label, prospective study at the E.I. Chazov National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation in 2024-2025 enrolled patients over 18 years of age with newly diagnosed idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with systemic sclerosis (PAH-SSc) in functional class II-III (WHO) who were prescribed tadalafil-based therapy (Tadacardil Canon, Canonpharma Production, Russia). A total of 47 pts aged 43.8 [37.5; 53.6] yrs were enrolled (28 IPAH pts, 19 PAH-SSD pts). The dose of tadalafil 20 mg once daily, if well tolerated and without hypotension, was increased to 40 mg once in all patients after 4 weeks. Starting monotherapy with tadalafil was prescribed to 11 low-risk patients, combination therapy with tadalafil and macitentan 10 mg/day – to 36 intermediate risk patients. Clinical and instrumental data [functional class, 6-minute walk test (6MWT) with determination of the degree of dyspnea according to Borg, capillary blood oxygen saturation (SpO2); NT-proBNP assessment, echocardiography (Echo), right heart catheterization (RHC)] were assessed at baseline and after 24±2 wks of therapy.

Results.

After 24 wks of treatment, the 6MWT distance in IPAH and PAH-SSD groups increased by 49.9 m…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free